应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NERV Minerva Neurosciences
休市中 08-23 16:00:00 EDT
2.63
+0.04
+1.54%
盘后
2.63
+0.00
0.00%
16:36 EDT
最高
2.75
最低
2.59
成交量
2.64万
今开
2.60
昨收
2.59
日振幅
6.18%
总市值
1,839万
流通市值
1,430万
总股本
699.34万
成交额
6.93万
换手率
0.49%
流通股本
543.69万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Minerva Neurosciences, Inc盘中异动 大幅上涨5.10%
自选股智能写手 · 08-20
Minerva Neurosciences, Inc盘中异动 大幅上涨5.10%
Minerva Neurosciences, Inc盘中异动 急速下挫5.30%报2.68美元
自选股智能写手 · 08-16
Minerva Neurosciences, Inc盘中异动 急速下挫5.30%报2.68美元
Minerva Neurosciences, Inc2024财年第二财季实现净利润-8.23百万美元,同比减少32.96%
自选股智能写手 · 08-11
Minerva Neurosciences, Inc2024财年第二财季实现净利润-8.23百万美元,同比减少32.96%
Minerva Neurosciences, Inc盘中异动 急速跳水5.40%
自选股智能写手 · 08-10
Minerva Neurosciences, Inc盘中异动 急速跳水5.40%
Minerva Neurosciences, Inc盘中异动 股价大涨5.00%
自选股智能写手 · 08-07
Minerva Neurosciences, Inc盘中异动 股价大涨5.00%
Minerva Neurosciences Inc 报告截至一月的季度业绩 - 收益摘要
Reuters · 08-06
Minerva Neurosciences Inc 报告截至一月的季度业绩 - 收益摘要
Minerva Neurosciences Inc 预计每股亏损 97 美分 - 财报前瞻
Reuters · 07-31
Minerva Neurosciences Inc 预计每股亏损 97 美分 - 财报前瞻
Minerva Neurosciences, Inc盘中异动 股价大涨5.47%
自选股智能写手 · 07-31
Minerva Neurosciences, Inc盘中异动 股价大涨5.47%
Minerva Neurosciences Inc 预计每股亏损 97 美分 - 财报前瞻
Reuters · 07-26
Minerva Neurosciences Inc 预计每股亏损 97 美分 - 财报前瞻
Minerva Neurosciences, Inc盘中异动 快速下跌5.18%报3.11美元
自选股智能写手 · 07-24
Minerva Neurosciences, Inc盘中异动 快速下跌5.18%报3.11美元
Minerva Neurosciences, Inc盘中异动 股价大涨6.69%
自选股智能写手 · 07-22
Minerva Neurosciences, Inc盘中异动 股价大涨6.69%
Minerva Neurosciences, Inc盘中异动 股价大涨8.63%报3.29美元
自选股智能写手 · 07-10
Minerva Neurosciences, Inc盘中异动 股价大涨8.63%报3.29美元
Minerva Neurosciences, Inc盘中异动 早盘股价大涨9.42%报3.37美元
自选股智能写手 · 07-03
Minerva Neurosciences, Inc盘中异动 早盘股价大涨9.42%报3.37美元
Minerva Neurosciences, Inc盘中异动 临近午盘股价大跌6.67%报2.94美元
自选股智能写手 · 06-27
Minerva Neurosciences, Inc盘中异动 临近午盘股价大跌6.67%报2.94美元
Minerva Neurosciences, Inc盘中异动 临近收盘快速下挫7.38%
自选股智能写手 · 06-26
Minerva Neurosciences, Inc盘中异动 临近收盘快速下挫7.38%
Minerva Neurosciences, Inc盘中异动 快速下挫5.19%报3.26美元
自选股智能写手 · 06-25
Minerva Neurosciences, Inc盘中异动 快速下挫5.19%报3.26美元
Minerva Neurosciences, Inc盘中异动 股价大跌5.70%报3.31美元
自选股智能写手 · 06-20
Minerva Neurosciences, Inc盘中异动 股价大跌5.70%报3.31美元
Minerva Neurosciences, Inc盘中异动 早盘股价大跌5.48%
自选股智能写手 · 06-18
Minerva Neurosciences, Inc盘中异动 早盘股价大跌5.48%
Minerva Neurosciences, Inc盘中异动 股价大涨5.11%报3.50美元
自选股智能写手 · 06-17
Minerva Neurosciences, Inc盘中异动 股价大涨5.11%报3.50美元
Minerva Neurosciences, Inc盘中异动 临近午盘股价大涨6.23%报3.07美元
自选股智能写手 · 06-04
Minerva Neurosciences, Inc盘中异动 临近午盘股价大涨6.23%报3.07美元
暂无数据
公司概况
公司名称:
Minerva Neurosciences
所属市场:
NASDAQ
上市日期:
--
主营业务:
Minerva Neurosciences, Inc.在Cyrenaic制药公司的名义下根据特拉华州法律于2007年4月23日成立。2013年11月,它合并了Sonkei制药有限公司以及合并后的公司更名为密涅瓦神经科学有限公司。作为合并,或Sonkei合并的结果,该公司有权在全球范围内开发,销售和进口MIN- 101和MIN -117,根据与三菱田边制药公司许可协议的权利,不包括亚洲大部分地区。公司通过收购Mind-NRG SA(或Mind-NRG)的股份,在2014年2月进一步扩大其产品候选组合,它具有独家开发和商业化MIN- 301,或 Mind-NRG 收购的权利。公司是一家临床阶段的生物制药公司,专注于发展和商业化候选产品的组合来治疗病人中枢神经系统(或 CNS)疾病。公司的主导候选产品是MIN- 101——它正在开发用于治疗精神分裂症的治疗化合物,和MIN -117 ——公司正在开发用于治疗重性抑郁障碍的痛苦治疗化合物(或MDD )。
发行价格:
--
{"stockData":{"symbol":"NERV","market":"US","secType":"STK","nameCN":"Minerva Neurosciences","latestPrice":2.63,"timestamp":1724443200000,"preClose":2.59,"halted":0,"volume":26449,"hourTrading":{"tag":"盘后","latestPrice":2.63,"preClose":2.63,"latestTime":"16:36 EDT","volume":5,"amount":13,"timestamp":1724445387344},"delay":0,"floatShares":5436892,"shares":6993406,"eps":-4.439976,"marketStatus":"休市中","marketStatusCode":7,"change":0.04,"latestTime":"08-23 16:00:00 EDT","open":2.6,"high":2.75,"low":2.59,"amount":69316.5420727,"amplitude":0.061776,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.439976,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724659200000},"adr":0,"listingDate":1404187200000,"adjPreClose":2.59,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":2.65,"preClose":2.62,"latestTime":"09:17 EDT","volume":300,"amount":796.0000200000001,"timestamp":1724419046900},"postHourTrading":{"tag":"盘后","latestPrice":2.63,"preClose":2.63,"latestTime":"16:36 EDT","volume":5,"amount":13,"timestamp":1724445387344},"volumeRatio":0.9983768703728991,"impliedVol":5.4722,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/NERV/tweets","defaultTab":"tweets","newsList":[{"id":"2460666650","title":"Minerva Neurosciences, Inc盘中异动 大幅上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460666650","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460666650?lang=zh_cn&edition=full","pubTime":"2024-08-20 03:34","pubTimestamp":1724096065,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日03时34分,Minerva Neurosciences, Inc股票出现波动,股价大幅拉升5.10%。Minerva Neurosciences, Inc股票所在的生物技术行业中,整体涨幅为0.98%。其相关个股中,Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Nucana Plc涨幅较大,Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Tonix Pharmaceuticals Holding Corp.较为活跃,换手率分别为9425.06%、3890.54%、1330.17%,振幅较大的相关个股有Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Revelation Biosciences Inc C/Wts 10/01/2027 ,振幅分别为448.55%、220.18%、198.02%。Minerva Neurosciences, Inc公司简介:Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082003342597199318&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082003342597199318&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV","BK4139"],"gpt_icon":0},{"id":"2459404596","title":"Minerva Neurosciences, Inc盘中异动 急速下挫5.30%报2.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459404596","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459404596?lang=zh_cn&edition=full","pubTime":"2024-08-16 03:18","pubTimestamp":1723749530,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日03时18分,Minerva Neurosciences, Inc股票出现异动,股价大幅下挫5.30%。Minerva Neurosciences, Inc股票所在的生物技术行业中,整体涨幅为1.18%。其相关个股中,Cingulate Inc.、Nutriband Inc C/Wts 、Immunoprecise Antibodies Ltd.涨幅较大,Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃,换手率分别为11090.24%、2351.65%、659.70%,振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cingulate Inc.、Nutriband Inc C/Wts ,振幅分别为163.33%、162.60%、115.79%。Minerva Neurosciences, Inc公司简介:Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。目标疾病包括精神分裂症、失眠症、抑郁障碍和帕金森病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081603185097198ddd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081603185097198ddd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV","BK4139"],"gpt_icon":0},{"id":"2458826776","title":"Minerva Neurosciences, Inc2024财年第二财季实现净利润-8.23百万美元,同比减少32.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458826776","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458826776?lang=zh_cn&edition=full","pubTime":"2024-08-11 00:19","pubTimestamp":1723306781,"startTime":"0","endTime":"0","summary":"8月11日,Minerva Neurosciences, Inc公布财报,公告显示公司2024财年第二财季净利润为-8.23百万美元,同比减少32.96%;其中营业收入为0.00美元,每股基本收益为-1.09美元。机构评级:截至2024年8月11日,当前有1家机构对Minerva Neurosciences, Inc目标价做出预测,其中目标均价为7.00美元,其中最低目标价为7.00美元,最高目标价为7.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408110019469f204aa8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408110019469f204aa8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV"],"gpt_icon":0},{"id":"2458519363","title":"Minerva Neurosciences, Inc盘中异动 急速跳水5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458519363","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458519363?lang=zh_cn&edition=full","pubTime":"2024-08-10 00:43","pubTimestamp":1723221832,"startTime":"0","endTime":"0","summary":"北京时间2024年08月10日00时43分,Minerva Neurosciences, Inc股票出现波动,股价急速下挫5.40%。Minerva Neurosciences, Inc股票所在的生物技术行业中,整体涨幅为2.00%。其相关个股中,Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Adma Biologics Inc涨幅较大,Azitra Inc、Salarius Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc.较为活跃,换手率分别为434.56%、96.44%、66.97%,振幅较大的相关个股有Azitra Inc、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Anew Medical Inc C/Wts 21/06/2029 ,振幅分别为90.93%、62.57%、37.04%。Minerva Neurosciences, Inc公司简介:Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。目标疾病包括精神分裂症、失眠症、抑郁障碍和帕金森病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240810004352af96d6f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240810004352af96d6f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"gpt_icon":0},{"id":"2457006468","title":"Minerva Neurosciences, Inc盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457006468","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457006468?lang=zh_cn&edition=full","pubTime":"2024-08-07 04:00","pubTimestamp":1722974458,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日04时00分,Minerva Neurosciences, Inc股票出现异动,股价急速拉升5.00%。Minerva Neurosciences, Inc股票所在的生物技术行业中,整体涨幅为1.26%。其相关个股中,Vbi Vaccines, Inc.、Alpha Tau Medical Ltd C/Wts 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 涨幅较大,Vbi Vaccines, Inc.、Tenax Therapeutics, Inc.、Cns Pharmaceuticals, Inc.较为活跃,换手率分别为1462.63%、1424.15%、587.91%,振幅较大的相关个股有Vbi Vaccines, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Alpha Tau Medical Ltd C/Wts ,振幅分别为168.52%、81.76%、78.49%。Minerva Neurosciences, Inc公司简介:Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807040058af9637de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807040058af9637de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"gpt_icon":0},{"id":"2457040956","title":"Minerva Neurosciences Inc 报告截至一月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2457040956","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457040956?lang=zh_cn&edition=full","pubTime":"2024-08-06 21:31","pubTimestamp":1722951088,"startTime":"0","endTime":"0","summary":" * Minerva Neurosciences Inc 报告了截至1月份的季度调整后每股亏损1.09美元,高于去年同期的每股亏损1.12美元。* 报告收入为零,分析师预期为零。* Minerva Neurosciences Inc 报告的本季度每股收益为亏损 1.09 美元。* 该公司当季亏损 823 万美元。* Minerva Neurosciences Inc 的股价本季度下跌了 12.2%,今年迄今为止下跌了 54.5%。* 在过去 30 天内,没有覆盖该公司的分析师对盈利预期进行修正。华尔街对 Minerva Neurosciences Inc 的 12 个月目标价中位数为 7.00 美元。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Minerva Neurosciences Inc 报告截至一月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NERV"],"gpt_icon":0},{"id":"2455340101","title":"Minerva Neurosciences Inc 预计每股亏损 97 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2455340101","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455340101?lang=zh_cn&edition=full","pubTime":"2024-07-31 21:58","pubTimestamp":1722434291,"startTime":"0","endTime":"0","summary":" * Minerva Neurosciences Inc 预计在8月2日公布截至2024年6月30日的财报时,季度收入将没有变化(预计)。* * LSEG 的分析师平均预计 Minerva Neurosciences Inc 每股亏损 97 美分。* 分析师对该公司股票的评级为 \"持有\"。* 华尔街对 Minerva Neurosciences Inc 的 12 个月目标价中值为 7.00 美元,高于其上一次收盘价 3.03 美元。7月31日 - 本摘要于北京时间7月31日13:58由机器生成。除非另有说明,所有数据均以美元为单位。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NERV"],"gpt_icon":0},{"id":"2455607149","title":"Minerva Neurosciences, Inc盘中异动 股价大涨5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455607149","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455607149?lang=zh_cn&edition=full","pubTime":"2024-07-31 03:56","pubTimestamp":1722369362,"startTime":"0","endTime":"0","summary":"北京时间2024年07月31日03时56分,Minerva Neurosciences, Inc股票出现波动,股价急速拉升5.47%。Minerva Neurosciences, Inc股票所在的生物技术行业中,整体涨幅为0.64%。其相关个股中,Imunon, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Celularity Inc C/Wts 16/07/2026 涨幅较大,Processa Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.、Imunon, Inc.较为活跃,换手率分别为2006.39%、1602.60%、1468.27%,振幅较大的相关个股有Imunon, Inc.、Processa Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.,振幅分别为78.15%、65.88%、59.59%。Minerva Neurosciences, Inc公司简介:Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。目标疾病包括精神分裂症、失眠症、抑郁障碍和帕金森病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024073103560296821a9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024073103560296821a9b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV","BK4139"],"gpt_icon":0},{"id":"2454400303","title":"Minerva Neurosciences Inc 预计每股亏损 97 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2454400303","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454400303?lang=zh_cn&edition=full","pubTime":"2024-07-26 21:51","pubTimestamp":1722001870,"startTime":"0","endTime":"0","summary":" * Minerva Neurosciences Inc 预计在7月30日发布业绩报告时,季度营收将保持不变。* * LSEG 的分析师平均预计 Minerva Neurosciences Inc 每股亏损 97 美分。* 分析师对该公司股票的评级为 \"持有\"。* 华尔街对 Minerva Neurosciences Inc 的 12 个月目标价中值为 7.00 美元,高于其上一次收盘价 3.12 美元。7月26日 - 本摘要于北京时间 7 月 26 日 13:51 机器生成。除非另有说明,否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NERV"],"gpt_icon":0},{"id":"2453836288","title":"Minerva Neurosciences, Inc盘中异动 快速下跌5.18%报3.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453836288","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453836288?lang=zh_cn&edition=full","pubTime":"2024-07-24 22:01","pubTimestamp":1721829662,"startTime":"0","endTime":"0","summary":"北京时间2024年07月24日22时01分,Minerva Neurosciences, Inc股票出现波动,股价快速跳水5.18%。Minerva Neurosciences, Inc股票所在的生物技术行业中,整体跌幅为0.28%。其相关个股中,Dermata Therapeutics, Inc.、Pieris Pharmaceuticals, Inc.、Dermata Therapeutics Inc C/Wts 涨幅较大,Dermata Therapeutics, Inc.、Azitra Inc、Gri Bio, Inc.较为活跃,换手率分别为5813.38%、1038.21%、572.31%,振幅较大的相关个股有Dermata Therapeutics, Inc.、Sangamo Therapeutics, Inc.、Dermata Therapeutics Inc C/Wts ,振幅分别为181.54%、82.71%、72.79%。Minerva Neurosciences, Inc公司简介:Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。目标疾病包括精神分裂症、失眠症、抑郁障碍和帕金森病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724220102941fa2ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724220102941fa2ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"gpt_icon":0},{"id":"2453792031","title":"Minerva Neurosciences, Inc盘中异动 股价大涨6.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453792031","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453792031?lang=zh_cn&edition=full","pubTime":"2024-07-22 23:31","pubTimestamp":1721662261,"startTime":"0","endTime":"0","summary":"北京时间2024年07月22日23时31分,Minerva Neurosciences, Inc股票出现波动,股价急速上涨6.69%。Minerva Neurosciences, Inc股票所在的生物技术行业中,整体涨幅为0.36%。其相关个股中,Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Apollomics Inc C/Wts 01/04/2028 、木薯科学涨幅较大,Hepion Pharmaceuticals, Inc.、Scisparc Ltd.、Mei Pharma, Inc.较为活跃,换手率分别为117.98%、108.02%、58.41%,振幅较大的相关个股有Anew Medical Inc C/Wts 21/06/2029 、木薯科学、Mei Pharma, Inc.,振幅分别为44.07%、33.41%、32.17%。Minerva Neurosciences, Inc公司简介:Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407222331019550133e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407222331019550133e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV","BK4139"],"gpt_icon":0},{"id":"2450381665","title":"Minerva Neurosciences, Inc盘中异动 股价大涨8.63%报3.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450381665","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450381665?lang=zh_cn&edition=full","pubTime":"2024-07-10 22:15","pubTimestamp":1720620946,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日22时15分,Minerva Neurosciences, Inc股票出现波动,股价快速拉升8.63%。截至发稿,该股报3.29美元/股,成交量2904股,换手率0.04%,振幅1.36%。Minerva Neurosciences, Inc股票所在的生物技术行业中,整体涨幅为0.33%。其相关个股中,Virpax Pharmaceuticals, Inc.、Longeveron Inc.、Kazia Therapeutics Limited涨幅较大,Virpax Pharmaceuticals, Inc.、Soligenix, Inc.、Longeveron Inc.较为活跃,换手率分别为2482.51%、1050.93%、680.36%,振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Kazia Therapeutics Limited,振幅分别为119.83%、83.64%、62.50%。Minerva Neurosciences, Inc公司简介:Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710221547941f5d81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710221547941f5d81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV","BK4139"],"gpt_icon":0},{"id":"2448859764","title":"Minerva Neurosciences, Inc盘中异动 早盘股价大涨9.42%报3.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448859764","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448859764?lang=zh_cn&edition=full","pubTime":"2024-07-03 21:50","pubTimestamp":1720014604,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日21时50分,Minerva Neurosciences, Inc股票出现异动,股价快速上涨9.42%。Minerva Neurosciences, Inc股票所在的生物技术行业中,整体跌幅为0.23%。其相关个股中,Effector Therapeutics Inc C/Wts 31/12/2025 、Cns Pharmaceuticals, Inc.、180 Life Sciences Corp C/Wts 07/11/2025涨幅较大,Cns Pharmaceuticals, Inc.、Annovis Bio, Inc.、Seastar Medical Holding Corporation较为活跃,换手率分别为3342.40%、21.93%、5.51%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Cns Pharmaceuticals, Inc.、Effector Therapeutics, Inc.,振幅分别为85.71%、61.11%、49.56%。Minerva Neurosciences, Inc公司简介:Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703215004af90661a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703215004af90661a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV","BK4139"],"gpt_icon":0},{"id":"2446935557","title":"Minerva Neurosciences, Inc盘中异动 临近午盘股价大跌6.67%报2.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446935557","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446935557?lang=zh_cn&edition=full","pubTime":"2024-06-27 23:37","pubTimestamp":1719502652,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日23时37分,Minerva Neurosciences, Inc股票出现波动,股价快速跳水6.67%。Minerva Neurosciences, Inc股票所在的生物技术行业中,整体跌幅为0.62%。其相关个股中,Geovax Labs Inc C/Wts 29/09/2025、Geovax Labs, Inc.、Nls Pharmaceutics Ltd.涨幅较大,Geovax Labs, Inc.、Kala Bio, Inc.、Nls Pharmaceutics Ltd.较为活跃,换手率分别为2190.73%、348.05%、313.93%,振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Geovax Labs, Inc.、Nls Pharmaceutics Ltd.,振幅分别为294.39%、127.05%、81.43%。Minerva Neurosciences, Inc公司简介:Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。目标疾病包括精神分裂症、失眠症、抑郁障碍和帕金森病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627233732aef6f3b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627233732aef6f3b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV","BK4139"],"gpt_icon":0},{"id":"2446875296","title":"Minerva Neurosciences, Inc盘中异动 临近收盘快速下挫7.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446875296","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446875296?lang=zh_cn&edition=full","pubTime":"2024-06-26 03:43","pubTimestamp":1719344615,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日03时43分,Minerva Neurosciences, Inc股票出现波动,股价急速下挫7.38%。Minerva Neurosciences, Inc股票所在的生物技术行业中,整体涨幅为1.27%。其相关个股中,Effector Therapeutics Inc C/Wts 31/12/2025 、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大,Cns Pharmaceuticals, Inc.、Effector Therapeutics, Inc.、Glycomimetics, Inc.较为活跃,换手率分别为1184.01%、241.98%、183.00%,振幅较大的相关个股有Effector Therapeutics Inc C/Wts 31/12/2025 、Cns Pharmaceuticals, Inc.、Glycomimetics, Inc.,振幅分别为272.73%、77.13%、47.00%。Minerva Neurosciences, Inc公司简介:Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062603433596816b04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062603433596816b04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"gpt_icon":0},{"id":"2446001325","title":"Minerva Neurosciences, Inc盘中异动 快速下挫5.19%报3.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446001325","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446001325?lang=zh_cn&edition=full","pubTime":"2024-06-25 00:18","pubTimestamp":1719245917,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日00时18分,Minerva Neurosciences, Inc股票出现波动,股价快速下跌5.19%。Minerva Neurosciences, Inc股票所在的生物技术行业中,整体涨幅为1.76%。其相关个股中,Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、阿里拉姆制药、Revelation Biosciences, Inc.涨幅较大,Revelation Biosciences, Inc.、Geovax Labs, Inc.、Effector Therapeutics, Inc.较为活跃,换手率分别为1838.56%、146.98%、92.60%,振幅较大的相关个股有Effector Therapeutics Inc C/Wts 31/12/2025 、Revelation Biosciences Inc C/Wts 10/01/2027 、Revelation Biosciences, Inc.,振幅分别为139.64%、65.32%、58.29%。Minerva Neurosciences, Inc公司简介:Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625001837aef655d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625001837aef655d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV","BK4139"],"gpt_icon":0},{"id":"2444249375","title":"Minerva Neurosciences, Inc盘中异动 股价大跌5.70%报3.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444249375","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444249375?lang=zh_cn&edition=full","pubTime":"2024-06-20 23:36","pubTimestamp":1718897812,"startTime":"0","endTime":"0","summary":"北京时间2024年06月20日23时36分,Minerva Neurosciences, Inc股票出现异动,股价大幅下跌5.70%。Minerva Neurosciences, Inc股票所在的生物技术行业中,整体跌幅为0.47%。其相关个股中,Geovax Labs Inc C/Wts 29/09/2025、Dermata Therapeutics Inc C/Wts 、Protagenic Therapeutics Inc C/Wts 29/04/2026 涨幅较大,Clearmind Medicine Inc.、Geovax Labs, Inc.、Trevena, Inc.较为活跃,换手率分别为405.96%、218.07%、187.25%,振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Seastar Medical Holding Corp C/Wts 28/10/2027 、Ocean Biomedical Inc C/Wts 14/02/2028 ,振幅分别为65507.52%、53.43%、52.63%。Minerva Neurosciences, Inc公司简介:Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620233653aef5dd7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620233653aef5dd7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV","BK4139"],"gpt_icon":0},{"id":"2444374544","title":"Minerva Neurosciences, Inc盘中异动 早盘股价大跌5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444374544","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444374544?lang=zh_cn&edition=full","pubTime":"2024-06-18 23:21","pubTimestamp":1718724086,"startTime":"0","endTime":"0","summary":"北京时间2024年06月18日23时21分,Minerva Neurosciences, Inc股票出现波动,股价急速跳水5.48%。Minerva Neurosciences, Inc股票所在的生物技术行业中,整体涨幅为0.04%。其相关个股中,Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Nls Pharmaceutics Ltd.涨幅较大,Mustang Bio, Inc.、Nls Pharmaceutics Ltd.、Qualigen Therapeutics, Inc.较为活跃,换手率分别为652.17%、580.34%、389.40%,振幅较大的相关个股有Nls Pharmaceutics Ltd.、Mustang Bio, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026,振幅分别为103.98%、52.69%、49.60%。Minerva Neurosciences, Inc公司简介:Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618232126af8e158e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618232126af8e158e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"gpt_icon":0},{"id":"2444316058","title":"Minerva Neurosciences, Inc盘中异动 股价大涨5.11%报3.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444316058","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444316058?lang=zh_cn&edition=full","pubTime":"2024-06-17 21:46","pubTimestamp":1718631969,"startTime":"0","endTime":"0","summary":"北京时间2024年06月17日21时46分,Minerva Neurosciences, Inc股票出现波动,股价急速上涨5.11%。截至发稿,该股报3.50美元/股,成交量1.0661万股,换手率0.15%,振幅4.50%。Minerva Neurosciences, Inc股票所在的生物技术行业中,整体涨幅为0.15%。其相关个股中,Mustang Bio, Inc.、Scinai Immunotherapeutics Ltd、Cns Pharmaceuticals, Inc.涨幅较大,Scinai Immunotherapeutics Ltd、Mustang Bio, Inc.、Cns Pharmaceuticals, Inc.较为活跃,换手率分别为3348.22%、580.53%、96.06%,振幅较大的相关个股有Mustang Bio, Inc.、Scinai Immunotherapeutics Ltd、Sellas Life Sciences Group, Inc.,振幅分别为80.69%、31.52%、20.67%。Minerva Neurosciences, Inc公司简介:Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061721461096814a20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061721461096814a20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV","BK4139"],"gpt_icon":0},{"id":"2440376572","title":"Minerva Neurosciences, Inc盘中异动 临近午盘股价大涨6.23%报3.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440376572","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440376572?lang=zh_cn&edition=full","pubTime":"2024-06-04 23:40","pubTimestamp":1717515610,"startTime":"0","endTime":"0","summary":"北京时间2024年06月04日23时40分,Minerva Neurosciences, Inc股票出现异动,股价大幅上涨6.23%。Minerva Neurosciences, Inc股票所在的生物技术行业中,整体涨幅为0.69%。其相关个股中,Annexon, Inc.、Cingulate Inc C/Wts 10/12/2026 、Cardio Diagnostics Holdings Inc C/Wts To Pur Com涨幅较大,Bio-Path Holdings, Inc.、Silo Pharma, Inc.、Annexon, Inc.较为活跃,换手率分别为72.21%、44.34%、40.32%,振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 29/04/2026 、Annexon, Inc.、Silo Pharma, Inc.,振幅分别为181.00%、35.37%、28.08%。Minerva Neurosciences, Inc公司简介:Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。目标疾病包括精神分裂症、失眠症、抑郁障碍和帕金森病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604234011af8bf137&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604234011af8bf137&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.minervaneurosciences.com","stockEarnings":[{"period":"1week","weight":0.0314},{"period":"1month","weight":-0.1807},{"period":"3month","weight":0.0772},{"period":"6month","weight":-0.6172},{"period":"1year","weight":-0.7058},{"period":"ytd","weight":-0.5724}],"compareEarnings":[{"period":"1week","weight":0.0141},{"period":"1month","weight":0.0386},{"period":"3month","weight":0.0617},{"period":"6month","weight":0.1069},{"period":"1year","weight":0.2867},{"period":"ytd","weight":0.1827}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Minerva Neurosciences, Inc.在Cyrenaic制药公司的名义下根据特拉华州法律于2007年4月23日成立。2013年11月,它合并了Sonkei制药有限公司以及合并后的公司更名为密涅瓦神经科学有限公司。作为合并,或Sonkei合并的结果,该公司有权在全球范围内开发,销售和进口MIN- 101和MIN -117,根据与三菱田边制药公司许可协议的权利,不包括亚洲大部分地区。公司通过收购Mind-NRG SA(或Mind-NRG)的股份,在2014年2月进一步扩大其产品候选组合,它具有独家开发和商业化MIN- 301,或 Mind-NRG 收购的权利。公司是一家临床阶段的生物制药公司,专注于发展和商业化候选产品的组合来治疗病人中枢神经系统(或 CNS)疾病。公司的主导候选产品是MIN- 101——它正在开发用于治疗精神分裂症的治疗化合物,和MIN -117 ——公司正在开发用于治疗重性抑郁障碍的痛苦治疗化合物(或MDD )。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.093479},{"month":2,"riseRate":0.2,"avgChangeRate":-0.109643},{"month":3,"riseRate":0.3,"avgChangeRate":-0.000761},{"month":4,"riseRate":0.5,"avgChangeRate":0.05689},{"month":5,"riseRate":0.6,"avgChangeRate":0.169154},{"month":6,"riseRate":0.6,"avgChangeRate":0.064983},{"month":7,"riseRate":0.3,"avgChangeRate":-0.047781},{"month":8,"riseRate":0.454545,"avgChangeRate":0.305453},{"month":9,"riseRate":0.4,"avgChangeRate":0.00871},{"month":10,"riseRate":0.2,"avgChangeRate":-0.236602},{"month":11,"riseRate":0.6,"avgChangeRate":0.100298},{"month":12,"riseRate":0.4,"avgChangeRate":-0.089821}],"exchange":"NASDAQ","name":"Minerva Neurosciences","nameEN":"Minerva Neurosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Minerva Neurosciences(NERV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Minerva Neurosciences(NERV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Minerva Neurosciences,NERV,Minerva Neurosciences股票,Minerva Neurosciences股票老虎,Minerva Neurosciences股票老虎国际,Minerva Neurosciences行情,Minerva Neurosciences股票行情,Minerva Neurosciences股价,Minerva Neurosciences股市,Minerva Neurosciences股票价格,Minerva Neurosciences股票交易,Minerva Neurosciences股票购买,Minerva Neurosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Minerva Neurosciences(NERV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Minerva Neurosciences(NERV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}